TRIDENT LIFELINE
Back to All Ratios
|
TRIDENT LIFELINE Last 5 Year EV/EBIT History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | |
---|---|---|---|
EV/EBIT(x) | 21.43 | 25.04 | 3.31 |
What is the latest EV/EBIT ratio of TRIDENT LIFELINE ?
Year | EV/EBIT |
---|---|
Mar2024 | 21.43 |
Mar2023 | 25.04 |
Mar2022 | 3.31 |
How is EV/EBIT of TRIDENT LIFELINE Trending?
Years | EV/EBIT | % Change | |
---|---|---|---|
Mar2024 | 21.43 | -14.42 | |
Mar2023 | 25.04 | 656.50 | |
Mar2022 | 3.31 | - |
Other Financial Ratios of TRIDENT LIFELINE
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/EBIT ratio of peers of TRIDENT LIFELINE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TRIDENT LIFELINE | ₹321.1 Cr | 0.6% | 2.1% | 89.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹394,115.0 Cr | 3.5% | -3.4% | -5.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,735.0 Cr | 3.7% | -10.2% | 25.6% | Stock Analytics | |
CIPLA | ₹126,313.0 Cr | 5.3% | 6.1% | -1.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,592.0 Cr | 1.4% | 4.6% | 7.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,095.0 Cr | 3.9% | 0% | -9.9% | Stock Analytics |
TRIDENT LIFELINE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TRIDENT LIFELINE | 0.6% |
2.1% |
89.1% |
SENSEX | -0% |
-2.4% |
1.2% |
You may also like the below Video Courses